RJA
ATEX icon

Raymond James & Associates’s Anterix ATEX Stock Holding History

Raymond James & Associates’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,855
Closed -$205K – 3591
2018
Q1 		$205K Sell
6,855
-900
-12% -$30.1K ﹤0.01% 3121
2017
Q4 		$249K Hold
7,755
– – ﹤0.01% 2934
2017
Q3 		$231K Sell
7,755
-1,750
-18% -$47.9K ﹤0.01% 2956
2017
Q2 		$221K Sell
9,505
-100
-1% -$2.32K ﹤0.01% 2921
2017
Q1 		$210K Hold
9,605
– – ﹤0.01% 2908
2016
Q4 		$217K Hold
9,605
– – ﹤0.01% 2838
2016
Q3 		$220K Hold
9,605
– – ﹤0.01% 2806
2016
Q2 		$205K Sell
9,605
-5,000
-34% -$157K ﹤0.01% 2640
2016
Q1 		$502K Sell
14,605
-900
-6% -$23.8K ﹤0.01% 2039
2015
Q4 		$426K Buy
15,505
+480
+3% +$13.1K ﹤0.01% 2067
2015
Q3 		$449K Buy
15,025
+1,050
+8% +$34.4K ﹤0.01% 1972
2015
Q2 		$589K Buy
+13,975
New +$660K ﹤0.01% 2010

Other funds holding ATEX

FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Raymond James & Associates's ATEX Position: Q2 2018 in Review

Raymond James & Associates sold out of Anterix (ATEX) in Q2 2018, closing a stake of 6,855 shares — an estimated $205K sold.

Raymond James & Associates first reported a position in ATEX in Q2 2015 and held it in 12 quarters. The position peaked at $589K in Q2 2015. 52 funds tracked by Wall St. Rank hold ATEX as of Q2 2018.

  • Raymond James & Associates reported no remaining Anterix position as of Q2 2018 after selling out during the quarter.
  • Raymond James & Associates sold 6,855 Anterix shares in Q2 2018, an estimated $205K.
  • Raymond James & Associates first reported a position in Anterix in Q2 2015 and held it in 12 quarters.
  • Raymond James & Associates's Anterix position peaked at $589K in Q2 2015.
  • 52 funds tracked by Wall St. Rank held Anterix as of Q2 2018.

Based on Raymond James & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.